您的购物车当前为空
别名 马来酸哌克昔林
Perhexiline maleate 是一种口服活性的 CPT1和 CPT2抑制剂,可降低脂肪酸的代谢。Perhexiline maleate 对大鼠心脏和肝脏CPT 1的IC50值分别为77 和 148 μM。

Perhexiline maleate 是一种口服活性的 CPT1和 CPT2抑制剂,可降低脂肪酸的代谢。Perhexiline maleate 对大鼠心脏和肝脏CPT 1的IC50值分别为77 和 148 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 367 | In stock | |
| 2 mg | ¥ 526 | In stock | |
| 5 mg | ¥ 823 | In stock | |
| 10 mg | ¥ 1,251 | In stock | |
| 25 mg | ¥ 2,277 | In stock | |
| 50 mg | ¥ 3,388 | In stock | |
| 100 mg | ¥ 4,710 | In stock | |
| 200 mg | ¥ 6,710 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 898 | In stock |
Perhexiline maleate 相关产品
| 产品描述 | Perhexiline maleate is an orally active inhibitor of CPT1 and CPT2 that reduces fatty acid metabolism. The IC50 values of perhexiline maleate against rat heart and liver CPT 1 were 77 and 148 μM, respectively. |
| 靶点活性 | CPT1 (rat liver):148 μM (IC50), CPT1 (rat heart):77 μM (IC50) |
| 体外活性 | Perhexiline处理提高了NB细胞对抗肿瘤治疗的敏感性。联合使用Perhexiline maleate能增强cisplatin降低NB细胞体外克隆形成潜力的效果[2]。 |
| 体内活性 | 与单独使用DMSO处理的小鼠相比,联合使用Perhexiline和cisplatin明显增强了抗肿瘤效果,显著改善了无病生存期。 |
| 别名 | 马来酸哌克昔林 |
| 分子量 | 393.56 |
| 分子式 | C23H39NO4 |
| CAS No. | 6724-53-4 |
| Smiles | OC(=O)\C=C\C(O)=O.C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 27.5 mg/mL (69.87 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容